New FPM prof doc

The board has approved a new position statement on the use of ketamine in the management of chronic non-cancer pain

PS12(PM) articulates the faculty's position on the use of ketamine in the management of patients with chronic non-cancer pain (CNCP) and acknowledges that there is wide variation in both clinical practice and reported effectiveness. This document is not a guideline for the use of ketamine in CNCP but offers guidance in this controversial arena, based on the literature and expert consensus, in order to inform the judgement of practitioners and to promote safety and quality for their patients.

We will pilot this prof doc for six months, and welcome feedback from faculty fellows and trainees until the end of 2021 via fpm@anzca.edu.au.
 

Last updated 11:21 2.07.2021